Has the core outcome (domain) set for vitiligo been implemented? An updated systematic review on outcomes and outcome measures in vitiligo randomized clinical …
V Eleftheriadou, C Bergqvist… - British Journal of …, 2023 - academic.oup.com
Background In 2015, a major achievement in vitiligo research was the development of an
internationally agreed upon core outcome domain set for randomized clinical trials (RCTs) …
internationally agreed upon core outcome domain set for randomized clinical trials (RCTs) …
Pro-pigmentary action of 5-fluorouracil through the stimulated secretion of CXCL12 by dermal fibroblasts
ZK Liao, SH Hu, BY Han, X Qiu, S Jiang… - Chinese Medical …, 2021 - mednexus.org
Background: There is growing evidence that 5-fluorouracil (5-FU) combined with therapeutic
trauma can effectively induce skin repigmentation in vitiligo patients who are unresponsive …
trauma can effectively induce skin repigmentation in vitiligo patients who are unresponsive …
Effectiveness and Tolerability of Various 5-Fluorouracil Formulations as Adjuvant Therapies for Vitiligo Management: A Systematic Review and Meta-Analysis
NA Kohaf, SM Sarsik, S Salman… - Current Reviews in …, 2024 - benthamdirect.com
Background All vitiligo treatments are restricted, and no known treatment reliably produces
repigmentation. In this study, we investigated the efficacy and safety of 5-Fluorouracil (5FU) …
repigmentation. In this study, we investigated the efficacy and safety of 5-Fluorouracil (5FU) …
The clinical and pathological effectiveness of microneedling and topical 5‐fluorouracil in vitiligo treatment: An association with matrix metalloproteinase 2 …
AG Abdou, AGA Farag, M Rashwan… - Journal of Cosmetic …, 2022 - Wiley Online Library
Background The current therapies for vitiligo require long duration with often disappointing
outcomes. 5‐Fluorouracil (5‐FU) is a chemotherapeutic agent approved for topical use in …
outcomes. 5‐Fluorouracil (5‐FU) is a chemotherapeutic agent approved for topical use in …
Microneedling in combination with topical pimecrolimus 1% versus topical pimecrolimus 1% for the treatment of refractory stable vitiligo: a randomized clinical trial
Objective. Vitiligo is a common, autoimmune disease that results in the destruction of the
melanocytes and manifests as depigmented macules on various areas of the skin …
melanocytes and manifests as depigmented macules on various areas of the skin …
Microneedling plus tacrolimus versus tacrolimus alone in conjunction with narrow band UVB in the treatment of vitiligo; A randomised control trial.
T Afzal, T Khalid, F Inam, B Bajwa… - The Professional …, 2024 - theprofesional.com
Objective: To compare the efficacy of microneedling plus Tacrolimus with narrow band UVB
versus tacrolimus with narrow band UVB in the treatment of vitiligo. Study Design …
versus tacrolimus with narrow band UVB in the treatment of vitiligo. Study Design …
[PDF][PDF] Research Article Microneedling in Combination with Topical Pimecrolimus 1% versus Topical Pimecrolimus 1% for the Treatment of Refractory Stable Vitiligo: A …
Objective. Vitiligo is a common, autoimmune disease that results in the destruction of the
melanocytes and manifests as depigmented macules on various areas of the skin …
melanocytes and manifests as depigmented macules on various areas of the skin …